SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in electroCore, Inc. of Class Action Lawsuit and Upcoming Deadline – ECOR

NEXT STORY
American Gene Technologies Hosts Celebration Event For Its First IND Submission (For HIV) To The Food and Drug Administration (FDA)
PREV STORY
Roche to present new data highlighting breadth of haematology portfolio and pipeline at the American Society of Hematology 2019 Annual Meeting
Subscribe to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Selecta Biosciences Presents Positive New Data from Ongoing Phase 2 Trial of SEL-212, in Development for Chronic Severe Gout, at PANLAR 2018 Congress

author_avatar
NASDAQ Market News

Opthea Confirms Final Patient Enrolment in Phase 2b Wet AMD Clinical Trial

MELBOURNE, Australia, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical stage ...

author_avatar
NASDAQ Market News

Stemline Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment Conference

NEW YORK, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a ...

author_avatar
NASDAQ Market News